Same Indication

Nivolumab vs Simvastatin

Nivolumab vs Simvastatin: Overview

This comparison examines the pharmacological differences between Nivolumab and Simvastatin.

Mechanism of Action

Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

Simvastatin: Prodrug converted to active form that inhibits HMG-CoA reductase.

Pharmacokinetics

Half-life: Nivolumab — 27 days; Simvastatin — 2 hours.

Chemical Properties

Molecular Formula: Simvastatin — C25H38O5.

Molecular Weight: Simvastatin — 418.5700 g/mol.

Type: Nivolumab — Antibody; Simvastatin — Small molecule.